Clinical trial
The Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects
NCT06622148 is registered in ClinicalTrials.gov with Sichuan Huiyu Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects
- Lead sponsor
- Sichuan Huiyu Pharmaceutical Co., Ltd
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 25, 2024
- Completion date
- July 26, 2024
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bioequivalency, safety issues